Baker Jessica Flechtner, Vp of Research at Genocea Biosciences Inc (NASDAQ:GNCA), has recently reported a series of transactions regarding this stock. Mrs. Flechtner acquired 8,115 shares of common stock, at prices ranging from $ 2.38 to $ 1.67 per share, as exercise or conversion of derivative security exempted pursuant to Rule 16b-3. In addition, Mrs. Flechtner sold 6,435 company shares, at an average weighted Price of $ 12 per share. Following these transactions, Mrs. Flechtner holds 1,680 shares, in a direct form.
During 2014, important company insiders have traded this stock. Directors Kevin Bitterman, Simeon George and Stephen Hoffman have purchased, respectively, 232,820 shares, 143,773 shares, and another 250,931 shares, each one at a price of $12 per share.
In addition, no important hedge funds are currently active at Genocea Biosciences Inc (NASDAQ:GNCA).